|
Resolution: standard / high Figure 2.
Cox proportional hazard model to estimate the rates of discontinuation according to
CYP2C19 phenotype (Hazard Ratio = 0.432 for each incremental change in phenotype, 95% Confidence
Interval 0.237 to 0.790, P = 0.006 after adjustment for current leflunomide dose, continuation of triple therapy
and positive rheumatoid factor at diagnosis).
Wiese et al. Arthritis Research & Therapy 2012 14:R163 doi:10.1186/ar3911 |
